Migraine trials in Spain

In Spain 19 Also abroad 249

19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Where
Barcelona, Sevilla, Valladolid
Age
6 years to 17 years
People
2,100 worldwide
Run by
Pfizer
See details and how to joinNCT04649242 · EU 2024-512743-23-00
Phase 3Taking people
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Where
Barcelona, Sevilla, Valladolid
Age
6 years to 17 years
People
600 worldwide
Run by
Pfizer
See details and how to joinNCT04743141 · EU 2024-512744-32-00
Phase 3Taking people
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Where
Barcelona, Madrid, Sevilla, Valencia, Vigo
Age
12 years to 17 years
People
285 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT04965675 · EU 2024-510656-13-00
No phaseTaking people
Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.
Where
Paiporta, Valencia
Age
16 years and over
People
87
Run by
Fundación Universidad Católica de Valencia San Vicente Mártir
See details and how to joinNCT05780450
Phase 3Taking people
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Where
Barcelona, Esplugues de Llobregat, Madrid, Móstoles, Sabadell, Santiago de Compostela, Sevilla, Valencia, Valladolid, Vigo
Age
6 years to 17 years
People
640 worldwide
Run by
Pfizer
See details and how to joinNCT05156398 · EU 2024-512382-13-00
Phase 3Taking people
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Where
Barcelona, Madrid, Sevilla, Valencia, Vigo
Age
6 years to 17 years
People
600 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT05164172 · EU 2022-502917-27-00
Phase 3Taking people
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Where
Barcelona, Madrid, Vigo
Age
6 years to 17 years
People
315 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT05897320 · EU 2022-502538-14-00
Phase 3Taking people
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Where
Barcelona, Madrid, Sevilla, Valencia
Age
6 years to 17 years
People
450 worldwide
Run by
AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Where
Barcelona, Chiclana De La Frontera, Madrid, Santander, Sevilla, Valladolid, Zaragoza
Age
18 years to 45 years
People
723 worldwide
Run by
Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00
No phaseTaking people
Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine
Where
Seville
Age
18 years to 65 years
People
60
Run by
University of Seville
See details and how to joinNCT07694063
No phaseNot yet taking people in Spain
Neurofeedback for Episodic Migraine
Where
Salamanca
Age
18 years and over
People
66
Run by
University of Salamanca
See details and how to joinNCT07661888
Phase 4Taking people
Randomized Cross-Over Experimental Trial of Treatment with Sumatriptan vs. Rimegepant During Nitroglycerin (NTG)-Induced Headache in Patients with Episodic Migraine for the Determination of Molecular and Clinical Biomarkers (MAMBO II Study).
Where
Barcelona
Age
18 years to 64 years
People
24
Run by
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
See details and how to join2024-519770-38-00 · EU 2024-519770-38-00
No phaseNot yet taking people in Spain
Migraine and Endometriosis: The FEMININE Study
Where
Barcelona
Age
18 years and over
People
150
Run by
Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07519343
No phaseEnrolling by invitation
Pericranial and General Sensitivity in Patients With Primary Headache
Where
Barcelona
Age
18 years and over
People
120
Run by
Universitat Internacional de Catalunya
See details and how to joinNCT07514208
No phaseNot yet taking people in Spain
Myotensive Extraocular Muscle Techniques Added to Manual Therapy for Migraine Without Aura
Where
Seville
Age
18 years to 65 years
People
84
Run by
Facultad de Enfermería, Fisioterapia y Podología (FEFP)
See details and how to joinNCT07254598
No phaseTaking people
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Where
Albacete, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Mollet del Vallès, Viladecans, Zaragoza
Age
18 years and over
People
700 worldwide
Run by
Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07159750
Phase 3Enrolling by invitation
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
Where
Barcelona, Madrid, Sevilla, Valencia
Age
6 years to 17 years
People
650 worldwide
Run by
AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00
No phaseTaking people
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Where
Barcelona
Age
6 years to 75 years
People
440
Run by
Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT06674772
Phase 4Not yet taking people in Spain
Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care
Where
Barcelona, Canet de Mar, Castelldefels, Cornellà de Llobregat, Girona, L'Hospitalet de Llobregat, Lleida, Molins de Rei, Palau-solità i Plegamans, Reus, Santa Coloma de Queralt, Sant Feliu de Llobregat, Tortosa
Age
18 years and over
People
460
Run by
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
See details and how to joinNCT06499116 · EU 2024-513597-22-00